R. Hoyer

Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis

T. Witzig, M. Lacy, N. Leung, 2007, American journal of hematology.

Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.

A. Tefferi, R. Hoyer, G. LeMarbre, 2007, Leukemia research.

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

T. Owonikoko, P. Roberts, J. Hamm, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.

E. Gehan, J. Marshall, J. Schlom, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.

T. Owonikoko, P. Roberts, J. Hamm, 2019 .

A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

Kimberly R. Jordan, A. Jimeno, S. Karam, 2022, Nature Cancer.

Trilaciclib (G1T28): A cyclin dependent kinase 4/6 inhibitor, in combination with etoposide and carboplatin (EP) for extensive stage small cell lung cancer (ES-SCLC)—Phase 1b results.

G. Shapiro, T. Owonikoko, M. Thomas, 2017 .

Stabilizing Intentional Overdoses in Freestanding Emergency Departments : A Good Idea ?

V. Tucci, Veronica Tucci, Syed Moiz Ahmed, 2017 .

Complications after traction removal of direct percutaneous endoscopic jejunostomy: three case reports.

T. Baron, A. Arora, R. Hoyer, 2005, Gastrointestinal endoscopy.